Efficacy and safety of proton pump inhibitors versus vonoprazan in treatment of erosive esophagitis: a PRISMA-compliant systematic review and network meta …
S Yang, W Deng, Z Xie, J Chen - Medicine, 2022 - journals.lww.com
Background: Proton-pump inhibitors (PPIs) and vonoprazan are recommended as first-line
therapies for erosive esophagitis (EE). However, it is uncertain how the magnitude of …
therapies for erosive esophagitis (EE). However, it is uncertain how the magnitude of …
Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship
Proton pump inhibitors (PPIs) have been available for over three decades and are among
the most commonly prescribed medications. They are effective in treating a variety of gastric …
the most commonly prescribed medications. They are effective in treating a variety of gastric …
The efficacy and safety of keverprazan, a novel potassium‐competitive acid blocker, in treating erosive oesophagitis: a phase III, randomised, double‐blind multicentre …
S Chen, D Liu, H Chen, A Liao, F Li… - Alimentary …, 2022 - Wiley Online Library
Background Keverprazan is a novel potassium‐competitive acid blocker (P‐CAB) with a
strong acid‐suppressive capacity that may provide clinical benefit in acid‐related diseases …
strong acid‐suppressive capacity that may provide clinical benefit in acid‐related diseases …
Induction and maintenance of healing in erosive esophagitis in the United States
R Yadlapati, E Hubscher, C Pelletier… - Expert Review of …, 2022 - Taylor & Francis
Introduction Erosive esophagitis (EE) occurs when refluxate from the stomach causes T-
lymphocyte infiltration of the esophageal mucosa, resulting in mucosal breaks. Currently …
lymphocyte infiltration of the esophageal mucosa, resulting in mucosal breaks. Currently …
[HTML][HTML] Gastroesophageal reflux disease increases susceptibility to nontuberculous mycobacterial pulmonary disease
Y Kim, JH Yoon, J Ryu, B Yang, SJ Chung, HK Kang… - Chest, 2023 - Elsevier
Background Gastroesophageal reflux disease (GERD) is a common comorbidity of
nontuberculous mycobacteria (NTM) pulmonary disease (PD). Although GERD is associated …
nontuberculous mycobacteria (NTM) pulmonary disease (PD). Although GERD is associated …
[HTML][HTML] On-demand versus continuous maintenance treatment with a proton pump inhibitor for mild gastroesophageal reflux disease: a prospective randomized …
YH Youn, HK Jung, SY Kim, CW Huh… - Journal of …, 2023 - ncbi.nlm.nih.gov
Methods Patients whose GERD symptoms improved after 4 weeks of standard dose PPI
treatment were prospectively enrolled at 25 hospitals. Subsequently, the enrolled patients …
treatment were prospectively enrolled at 25 hospitals. Subsequently, the enrolled patients …
[HTML][HTML] Endoscopic radiofrequency Stretta therapy reduces proton pump inhibitor dependency and the need for anti-reflux surgery for refractory gastroesophageal …
A Joel, A Konjengbam, Y Viswanath… - Clinical …, 2024 - ncbi.nlm.nih.gov
Methods A tertiary UK center evaluated all patients with refractory GERD who underwent
Stretta between 2014 and 2022. Patients and primary care professionals were contacted to …
Stretta between 2014 and 2022. Patients and primary care professionals were contacted to …
[HTML][HTML] Recent insights on functional heartburn and reflux hypersensitivity
E Savarino, E Marabotto… - Current Opinion in …, 2022 - journals.lww.com
The better ability to interpret impedance-pH tracings together with earlier data on the
different prevalence of microscopic esophagitis in RH and FH patients, and recent studies …
different prevalence of microscopic esophagitis in RH and FH patients, and recent studies …
Diagnostic accuracy of gastroesophageal reflux disease questionnaire for gastroesophageal reflux disease: A systematic review and meta‐analysis
DM Simadibrata, E Ngadiono… - …, 2023 - Wiley Online Library
Background The use of a symptom‐based gastroesophageal reflux disease (GERD)
questionnaire (GerdQ) for GERD diagnosis has gained interest due to its greater efficacy …
questionnaire (GerdQ) for GERD diagnosis has gained interest due to its greater efficacy …
Possible Association between the Use of Proton Pump Inhibitors and H2 Receptor Antagonists, and Esophageal Cancer: A Nested Case–Control Study Using a …
Although safety concerns regarding proton pump inhibitor (PPI)/H2-receptor antagonists
(H2RA) in the incident esophageal cancer have been raised, the Asian-based report is …
(H2RA) in the incident esophageal cancer have been raised, the Asian-based report is …